Answers are grounded in this paper and cite their sources.
Over the past decade, it has been increasingly recognized that obesity is not only associated with an increased risk of cardiovascular and metabolic disease, but there are also previously unsuspected associations with gastrointestinal disease as well (including esophageal cancer and its precursors, and nonalcoholic fatty liver disease).1–3 The current issue of the Journal of Clinical Gastroenterology features a paper by Anderson et al4 that suggests we may need to add colorectal polyps to the list. The importance of colonic polyp identification and removal for the prevention of colorectal cancer is abundantly clear. Comprehensive strategies are in place that individualize screening based on stratification of risk, for example, higher intensity regimens for those with a family or personal history of colorectal adenoma or carcinoma. Critical to the ongoing effectiveness of screening strategies is the recognition that at-risk groups may change and new risk factors may be identified. Incorporating risk factors in addition to genetic predispositions or personal history will help streamline an already over-burdened health care system, targeting at-risk individuals for the greatest scrutiny, while decreasing resources devoted to low-risk individuals. Although the incidence of colorectal cancer and adenomas seems to be decreasing,5 our nation's ever-growing collective body mass index (BMI) stands out as a concern, given the suspected association between adiposity and risk of polyp formation. Multiple studies have been performed over the last 15 years to assess this connection, with varying results.6–14 Anderson et al report their findings of a cross-sectional study of 2493 patients undergoing screening colonoscopy, stratified by BMI, and adjusted for alcohol, tobacco, and nonsteroidal anti-inflammatory drug use. The study's primary finding was of a significant risk of colorectal neoplasia with increasing BMI. As other studies have demonstrated, there was a significant correlation between BMI and colonic adenomas in women, strongest in women with a BMI over 40. Although the association was not statistically significant for men, there was a strong trend, supporting an overall correlation between BMI and polyps. Among the prevalence data, the most striking finding was a 25% occurrence of advanced colonic neoplasia in women with a BMI over 40, a startling and disturbing result. Although no connection was found between colonic neoplasia and type 2 diabetes, the study was not designed to assess this association, and other recent studies have demonstrated that diabetes is likely a risk factor.15,16 Unlike prior studies, no difference was found between premenopausal and postmenopausal women. While the exact cause of the increased risk of adenomas is unclear, increased insulin, insulin-like growth factor, a change in motility, physical activity, and dietary fat and protein content have all been hypothesized.17–22 A connection between obesity, high-fat diets, and colonic adenomas has long been postulated.23 Although previous studies have shown some conflicting results, this is one of the most definitive studies to date that demonstrates a link between obesity and colonic adenomas. As the epidemic of obesity washes over the United States and indeed, most of the world, the recognition of this major new risk factor is important to ensure that colorectal cancer rates do not begin to reverse their recent decline. If confirmed by other studies, the current study suggests that our screening strategies would be more successful if they recognized the increased risk associated with obesity. Further, these data raise the possibility that future rates of colorectal neoplasia could be further attenuated if the rise in obesity could be stemmed. Alarming is the fact that, although at higher risk of colonic polyps, obese patients are less likely to undergo standard screening.24 Even more disturbing is the increase in colorectal cancer rates among patients under the age of 50, a group also experiencing skyrocketing rates of obesity.25 One cannot help but predict an impending spike in colorectal cancer rates in this country over the next several decades. Areas that should be the subject of future research include identifying the relative importance of obesity per se and its attendant dietary concomitants, and whether and on what time scale reducing BMI reduces the level of risk of neoplasia. While it is important that we recognize obesity as a new risk factor to augment our screening strategies, at best a change in screening strategy is only a bandage covering a much more important and dangerous issue. Until we become better at aggressively stopping the rise of obesity, our health care system will continue to be stretched beyond its limits, and the list of attendant medical risks (including some gastrointestinal risks) will continue to grow.
No takes yet. Share an insight, caveat, or question.
Cheskin et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: